“Steroid-Refractory Chronic Graft-Versus-Host Disease Treated With Ruxolitinib: A Narrative Review of Symptom Burden and Return to Daily Life”. Journal of Clinical Case Studies and Reviews, vol. 4, no. 1, Nov. 2023, pp. 31-36, https://doi.org/10.5281/zenodo.22227762.